ASTERDM767.95

Aster DM Healthcare Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersAPOLLOHOSPMAXHEALTHKIMSCOHANCEWOCKPHARMASYNGENEGLANDLALPATHLABMcap ₹39,790 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations3,698.94,138.54,643.24,876.0
Other Income24.9148.2125.6129.5
Total Income3,723.84,286.74,768.85,005.5
Expenses
+ Purchases of Stock-in-Trade927.5920.21,047.61,100.8
+ Changes in Inventories-11.618.21.2-7.4
+ Employee Benefit Expense675.9760.4848.1895.5
+ Finance Costs110.3123.8123.0123.4
+ Depreciation & Amortisation220.0248.8264.3270.3
+ Other Expenses1,529.21,675.21,845.31,929.1
Total Expenses3,451.23,746.64,129.44,311.8
EBITDA578.0764.5901.0958.0
EBIT358.0515.7636.8687.7
Profit
PBT before Exceptional Items272.5540.1639.4693.7
+ Exceptional Items0.0-50.1-32.7-142.7
Pretax Income272.5490.0606.7551.0
+ Current Tax32.4125.7186.0199.0
+ Deferred Tax24.18.6-43.4-50.5
Tax Expense56.5134.4142.6148.5
+ Share of Associates & JVs-11.3-18.9-37.0-39.7
Net Income211.65,407.9427.1362.8
+ Net Income — Continuing Ops216.0355.6464.1402.5
+ Net Income — Discontinued Ops6.95,071.20.00.0
+ Other Comprehensive Income46.4-2.10.40.9
Total Comprehensive Income258.05,405.8427.5363.7
Net Income to Common129.35,377.8388.1318.7
Minority Interest82.330.139.044.1
Per Share
Basic EPS2.60107.987.536.18
Diluted EPS2.60107.857.526.17
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs28.20.00.0
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax69.15,071.20.00.0
+ Tax — Discontinued Operations62.20.00.00.0
Other Comprehensive Income — detail
+ Other Comprehensive Income-2.10.40.9
+ Items NOT to be Reclassified to P&L13.9-3.1-0.2
+ Tax on Items NOT to be Reclassified-0.8-0.1
+ Tax on Items NOT to be Reclassified — alt tag1.5
+ Items to be Reclassified to P&L44.20.30.71.4
+ Tax on Items to be Reclassified0.10.20.4
+ Tax on Items to be Reclassified — alt tag10.2
Comprehensive Income — Owners of Parent42.65,375.8388.5319.6
Comprehensive Income — Non-controlling Interests3.830.038.944.1
Per Share — as-filed variants
Basic EPS — Continuing Operations3.606.167.536.18
Diluted EPS — Continuing Operations3.606.157.526.17
Basic EPS — Discontinued Operations-1.00101.820.000.00
Diluted EPS — Discontinued Operations-1.00101.700.000.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit2,783.03,200.13,594.43,782.6
Gross Margin %75.2477.3377.4177.58
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)272.5540.1639.4693.7
− Exceptional Items (reconciliation)0.0-50.1-32.7-142.7
Net Income Adj (tax-effected)211.65,444.3452.1467.1
EPS Adj2.60108.717.977.96
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.0010.00
Paid Up Equity Capital499.5499.5518.1518.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.